StimCardio raised $30 million in Series A financing to fund its pivotal study and preparation for an FDA De Novo submission.
- Amount
- $30M
- Stage
- Series A
- Announced
- 29 October 2026
- Lead
- Metis Medtech
- Other investors
- Catalyst Health Ventures
- Use of funds
- Fund planned NeuroPulse 2 pivotal study and preparation for De Novo submission to the FDA.
- Checked
- Announced by the company